Overexpression of sonic hedgehog in the triple negative breast cancer: clinicopathological characteristics of high burden breast cancer patients from Bangladesh
SCIENTIFIC REPORTS (2016)
作者
我是这篇论文的作者
推荐
Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
Florence Boissiere-Michot, Ghita Chabab, Caroline Mollevi, Severine Guiu, Evelyne Lopez-Crapez, Jeanne Ramos, Nathalie Bonnefoy, Virginie Lafont, William Jacot
CANCERS (2021)
HOXB7 Overexpression Leads Triple-Negative Breast Cancer Cells to a Less Aggressive Phenotype
Simone Aparecida de Bessa Garcia, Mafalda Araujo, Tiago Pereira, Renata Freitas
BIOMEDICINES (2021)
Pembrolizumab in Triple-Negative Breast Cancer
Ryan Sun, Lee-Jen Wei
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Pembrolizumab in Early Triple-Negative Breast Cancer
Shuvadeep Ganguly, Ajay Gogia
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer
Florence Boissiere-Michot, Marie-Christine Chateau, Simon Thezenas, Severine Guiu, Angelique Bobrie, William Jacot
FRONTIERS IN IMMUNOLOGY (2022)
Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway
Mengjie Li, Tingting Guo, Jiayi Lin, Xia Huang, Qiaodan Ke, Yujian Wu, Chunping Fang, Chenxia Hu
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Immunotherapy for Triple-Negative Breast Cancer
Yifeng Cao, Chuyang Chen, Yi Tao, Weifeng Lin, Ping Wang
PHARMACEUTICS (2021)
Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells
Saber Yari Bostanabad, Senem Noyan, Bala Gur Dedeoglu, Hakan Gurdal
SCIENTIFIC REPORTS (2021)
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
Lisa Agnello, Annachiara d'Argenio, Alessandra Caliendo, Roberto Nilo, Antonella Zannetti, Monica Fedele, Simona Camorani, Laura Cerchia
CELLS (2023)
Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer
Qian Yao, Wei Hou, Junbing Chen, Yanhua Bai, Mengping Long, Xiaozheng Huang, Chen Zhao, Lixin Zhou, Dongfeng Niu
FRONTIERS IN MEDICINE (2022)
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
A. Bardia, S. A. Hurvitz, S. M. Tolaney, D. Loirat, K. Punie, M. Oliveira, A. Brufsky, S. D. Sardesai, K. Kalinsky, A. B. Zelnak, R. Weaver, T. Traina, F. Dalenc, P. Aftimos, F. Lynce, S. Diab, J. Cortes, J. O'Shaughnessy, V Dieras, C. Ferrario, P. Schmid, L. A. Carey, L. Gianni, M. J. Piccart, S. Loibl, D. M. Goldenberg, Q. Hong, M. S. Olivo, L. M. Itri, H. S. Rugo
NEW ENGLAND JOURNAL OF MEDICINE (2021)
EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry
Haitao Luan, Timothy A. Bielecki, Bhopal C. Mohapatra, Namista Islam, Insha Mushtaq, Aaqib M. Bhat, Sameer Mirza, Sukanya Chakraborty, Mohsin Raza, Matthew D. Storck, Michael S. Toss, Jane L. Meza, Wallace B. Thoreson, Donald W. Coulter, Emad A. Rakha, Vimla Band, Hamid Band
ELIFE (2023)
Pathology of triple negative breast cancer
Filippo Borri, Annarita Granaglia
SEMINARS IN CANCER BIOLOGY (2021)
Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment
Tai-Hua Tsai, Ching-Chieh Yang, Tai-Chih Kou, Chang-En Yang, Jia-Zih Dai, Chia-Ling Chen, Cheng-Wei Lin
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
H3K27me3 conditions chemotolerance in triple-negative breast cancer
Justine Marsolier, Pacome Prompsy, Adeline Durand, Anne-Marie Lyne, Camille Landragin, Amandine Trouchet, Sabrina Tenreira Bento, Almut Eisele, Sophie Foulon, Lea Baudre, Kevin Grosselin, Mylene Bohec, Sylvain Baulande, Ahmed Dahmani, Laura Sourd, Eric Letouze, Anne-Vincent Salomon, Elisabetta Marangoni, Leila Perie, Celine Vallot
NATURE GENETICS (2022)
Tocilizumab inhibits IL-8 and the proangiogenic potential of triple negative breast cancer cells
Noura N. Alraouji, Abdelilah Aboussekhra
MOLECULAR CARCINOGENESIS (2021)
Cucurbitacin I (JSI-124)-dependent inhibition of STAT3 permanently suppresses the pro-carcinogenic effects of active breast cancer-associated fibroblasts
Bothaina Al-Harbi, Abdelilah Aboussekhra
MOLECULAR CARCINOGENESIS (2021)
Eugenol modulates genomic methylation and inactivates breast cancer-associated fibroblasts through E2F1-dependent downregulation of DNMT1/DNMT3A
Layla A. Al-Kharashi, Tala Bakheet, Wejdan A. AlHarbi, Nisreen Al-Moghrabi, Abdelilah Aboussekhra
MOLECULAR CARCINOGENESIS (2021)
CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia
Sivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, Souichi Takasugi, Ayano Nakamura, Miyuki Takahashi, Kaori Uchino, Satsuki Murakami, Md Wahiduzzaman, Lam Quang Vu, Md Lutfur Rahman, Muhammad Nazmul Hasan, Toshinori Hyodo, Hiroyuki Konishi, Shinobu Tsuzuki, Kazuhiro Yoshikawa, Susumu Suzuki, Ryuzo Ueda, Masayuki Ejiri, Yoshitaka Hosokawa, Akiyoshi Takami
CELL DEATH DISCOVERY (2021)
Osteoprotegerin (OPG) mediates the anti-carcinogenic effects of normal breast fibroblasts and targets cancer stem cells through inhibition of the β-catenin pathway
Noura N. Alraouji, Siti-Fauziah Hendrayani, Hazem Ghebeh, Falah H. Al-Mohanna, Abdelilah Aboussekhra
CANCER LETTERS (2021)
Tocilizumab suppresses the pro-carcinogenic effects of breast cancer-associated fibroblasts through inhibition of the STAT3/AUF1 pathway
Naif Al-Jomah, Falah H. Al-Mohanna, Abdelilah Aboussekhra
CARCINOGENESIS (2021)
Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking
Md Lutfur Rahman, Toshinori Hyodo, Sivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan, Yuko Mihara, Md Wahiduzzaman, Shinobu Tsuzuki, Yoshitaka Hosokawa, Hiroyuki Konishi
SCIENTIFIC REPORTS (2021)
Correction of a CD55 mutation to quantify the efficiency of targeted knock-in via flow cytometry
Md. Lutfur Rahman, Toshinori Hyodo, Muhammad Nazmul Hasan, Yuko Mihara, Sivasundaram Karnan, Akinobu Ota, Shinobu Tsuzuki, Yoshitaka Hosokawa, Hiroyuki Konishi
MOLECULAR BIOLOGY REPORTS (2022)
High DNMT1 Expression in Stromal Fibroblasts Promotes Angiogenesis and Unfavorable Outcome in Locally Advanced Breast Cancer Patients
Layla A. Al-Kharashi, Asma Tulbah, Maria Arafah, Abdelmonneim M. Eldali, Taher Al-Tweigeri, Abdelilah Aboussekhra
FRONTIERS IN ONCOLOGY (2022)
Genetic alterations of Keap1 confers chemotherapeutic resistance through functional activation of Nrf2 and Notch pathway in head and neck squamous cell carcinoma
Syed S. Islam, Khawlah Qassem, Shafiqul Islam, Rashed R. Parag, Mohammed Z. Rahman, Walid A. Farhat, Herman Yeger, Abdelilah Aboussekhra, Bedri Karakas, Abu Shadat M. Noman
CELL DEATH & DISEASE (2022)
Osteoprotegerin (OPG) Upregulation Activates Breast Stromal Fibroblasts and Enhances Their Pro-Carcinogenic Effects through the STAT3/IL-6 Signaling
Huda K. Al-Nasrallah, Mysoon M. Al-Ansari, Abdelilah Aboussekhra
CELLS (2022)
RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity
David Barua, Afrin Sultana, Md Nahidul Islam, Fergus Cox, Ananya Gupta, Sanjeev Gupta
BMC CANCER (2023)
The curcumin analogue PAC has potent anti-anaplastic thyroid cancer effects
Mai Al-Mohanna, Noura N. Alraouji, Samiah A. Alhabardi, Falah Al-Mohanna, Basem Al-Otaibi, Ibrahim Al-Jammaz, Abdelilah Aboussekhra
SCIENTIFIC REPORTS (2023)
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma
Sivasundaram Karnan, Akinobu Ota, Hideki Murakami, Md. Lutfur Rahman, Md Wahiduzzaman, Muhammad Nazmul Hasan, Lam Quang Vu, Ichiro Hanamura, Akihito Inoko, Miho Riku, Hideaki Ito, Yoshifumi Kaneko, Toshinori Hyodo, Hiroyuki Konishi, Shinobu Tsuzuki, Yoshitaka Hosokawa
CELL DEATH DISCOVERY (2023)
High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patients
Taher Al-Tweigeri, Noura N. AlRaouji, Asma Tulbah, Maria Arafah, Mouad Aboussekhra, Falah Al-Mohanna, Ahmed Mostafa Gad, Abdelmonneim M. Eldali, Tusneem A. Elhassan, Abdelilah Aboussekhra
BREAST CANCER RESEARCH (2022)